Eisana | Carole Spangler Vaughn

Carole Spangler Vaughn, CEO of Eisana, presented at 1StartupWorld, introducing her company's solution to chemotherapy-induced peripheral neuropathy—a debilitating side effect affecting millions. Her approach, born from personal experience with breast cancer, involves a novel device that cools the extremities during chemotherapy to prevent nerve damage. This method allows patients to maintain mobility and dexterity, enhancing treatment compliance and quality of life. Eisana's direct-to-consumer model ensures broader access to this innovative treatment, bypassing traditional limitations of clinic-based therapies. Carole's blend of scientific expertise and entrepreneurial vision exemplifies leadership in healthcare innovation.